Characterisation of tumour infiltrating lymphocytes and correlations with immunological surface molecules in colorectal cancer

European Journal of Cancer

Volumn 35, Issue 5, 1999, Pages 721-726

  Diederichsen, A C P ^a   Zeuthen, J ^b   Christensen, P B ^a   Kristensen, T ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

Colorectal cancer; Enzymes; Flow cytometry; Surface markers; Tumour infiltrating lymphocytes

Indexed keywords

B7 ANTIGEN; CD16 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INTERLEUKIN 2 RECEPTOR; LYMPHOCYTE SURFACE MARKER; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLONAL ANERGY; COLON ADENOCARCINOMA; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; RECTUM CARCINOMA; T LYMPHOCYTE SUBPOPULATION; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD80; CD4-CD8 RATIO; COLORECTAL NEOPLASMS; FEMALE; FLOW CYTOMETRY; GENES, MHC CLASS I; GENES, MHC CLASS II; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; SURVIVAL ANALYSIS;

EID: 0033001312     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00033-7     Document Type: Article

References (21)

1. Andersen S.N., Rognum T.O., Lund E., Meling G.I., Hauge S. Strong HLA-DR expression in large bowel carcinomas is associated with good prognosis. Br. J. Cancer. 68:1993;80-85.
2. Lazaris A.C., Theodoropoulos G.E., Davaris P.S., et al. Heat shock protein 70 and HLA-DR molecules tissue expression. Prognostic implications in colorectal cancer. Dis. Colon. Rectum. 38:1995;739-745.
3. Möller P., Momburg F., Koretz K., et al. Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma. Cancer Res. 51:1991;729-736.
4. Diederichsen A.C.P., Stenholm A.C.O., Kronborg O., et al. Flow cytometric investigation of immune-response-related surface molecules on human colorectal cancers. Int. J. Cancer (Pred Oncol). 79:1998;283-287.
5. Chaux P., Moutet M., Faivre J., Martin F., Martin M. Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation. Lab. Invest. 74:1996;975-983.
6. Jass J.R., Love S.B., Northover J.M. A new prognostic classification of rectal cancer. Lancet. 1:1987;1303-1306.
7. Di Giorgio A., Botti C., Tocchi A., Mingazzini P., Flammia M. The influence of tumor lymphocytic infiltration on long term survival of surgically treated colorectal cancer patients. Int. Surg. 77:1992;256-260.
8. Østenstad B., Lea T., Schlichting E., Harboe M. Human colorectal tumour infiltrating lymphocytes express activation markers and the CD45RO molecule, showing a primed population of lymphocytes in the tumour area. Gut. 35:1994;382-387.
9. Matsuda M., Petersson M., Lenkei R., et al. Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease. Int. J. Cancer. 61:1995;765-772.
10. Håkansson L., Adell G., Boeryd B., Sjögren F., Sjödahl R. Infiltration of mononuclear inflammatory cells into primary colorectal carcinomas: an immunohistological analysis. Br. J. Cancer. 75:1997;374-380.
11. Dukes C.E., Bussey H.J.R. The spread of rectal cancer and its effect on prognosis. Br. J. Cancer. 12:1958;309-320.
12. Turnbull Jr R.B., Kyle K., Watson F.R., Spratt J. Cancer of the colon: the influence of the no-touch isolation technique on survival rates. Ann. Surg. 166:1967;420-427.
13. Diederichsen A.C.P., Hansen T.P., Nielsen O., et al. A comparison of flow cytometry and immunohistochemistry in human colorectal cancers. Acta Path. Microbiol. Immunol. Scand. 106:1998;562-570.
14. Ebert E.C., Brolin R.E., Roberts A.I. Characterization of activated lymphocytes in colon cancer. Clin. Immunol. Immunopathol. 50:1989;72-81.
15. Mulder W.M., Koenen H., van de Muysenberg A.J., Bloemena E., Wagstaff J., Scheper R.J. Reduced expression of distinct T-cell CD molecules by collagenase/DNase treatment. Cancer Immunol. Immunother. 38:1994;253-258.
16. Ford A.L., Foulcher E., Goodsall A.L., Sedgwick J.D. Tissue digestion with dispase substantially reduces lymphocyte and macrophage cell-surface antigen expression. J. Immunol. Meth. 194:1996;71-75.
17. Abuzakouk M., Feighery C., O'Farrelly C. Collagenase and dispase enzymes disrupt lymphocyte surface molecules. J. Immunol Meth. 194:1996;211-216.
18. Wimmenauer S., Keller H., Rahner S., et al. Phenotypical and functional characteristics of tumor-infiltrating lymphocytes from colon carcinomas stimulated with rIL-2 and rIL-4 in vitro: comparison with lymphocytes of the normal colon mucosa and the peripheral blood. Anticancer Res. 14:1994;963-968.
19. Watanabe N., Hizuta A., Tanaka N., Orita K. Localization of T cell receptor (TCR) gamma delta+T cells into human colorectal cancer: flow cytometric analysis of TCR-gamma delta expression in tumour-infiltrating lymphocytes. Clin. Exp. Immunol. 102:1995;167-173.
20. Ljunggren H.G., Kärre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today. 11:1990;237-244.
21. Schwartz R.H. A cell culture model for T lymphocyte clonal anergy. Science. 248:1990;1349-1356.